Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets.
about
Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug developmentThe p38 MAPK inhibitor, SB203580, inhibits cell invasion by Neospora caninum.Activation of a Neospora caninum EGFR-Like Kinase Facilitates Intracellular Parasite Proliferation.Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.
P2860
Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@en
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@nl
type
label
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@en
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@nl
prefLabel
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@en
Serine Proteases of Malaria Pa ...... as Antimalarial Drug Targets.
@nl
P2860
P921
P356
P1476
Serine Proteases of Malaria Pa ...... l as Antimalarial Drug Targets
@en
P2093
Asrar Alam
P2860
P304
P356
10.1155/2014/453186
P50
P577
2014-03-11T00:00:00Z